Study of PKRBD in HCV genotype 3a infected patients in response to interferon therapy in Pakistani population
Authors:
Open Access
- 9 December 2013
- journal article
- Published by Springer Nature in Virology Journal
- Vol. 10 (1) , 352
Abstract
Hepatitis C virus (HCV) is a major cause of liver cirrhosis and hepatocellular carcinoma and infects about 3% world population. Response to interferon therapy depends upon the genotype of the virus and factors associated with the host. Despite a good response to interferon therapy, a considerable number of genotype 3a infected patients remains unalleviated.Keywords
This publication has 41 references indexed in Scilit:
- Improving the Physical Realism and Structural Accuracy of Protein Models by a Two-Step Atomic-Level Energy MinimizationBiophysical Journal, 2011
- Response to combination therapy of HCV 3a infected Pakistani patients and the role of NS5A proteinVirology Journal, 2011
- Twenty-four weeks of pegylated interferon plus ribavirin effectively treat patients with HCV genotype 6aJournal of Viral Hepatitis, 2010
- Prediction of prognostic biomarkers for Interferon-based therapy to Hepatitis C Virus patients: a metaanalysis of the NS5A protein in subtypes 1a, 1b, and 3aVirology Journal, 2010
- I-TASSER: a unified platform for automated protein structure and function predictionNature Protocols, 2010
- Genetic diversity of NS5A protein from hepatitis C virus genotype 3a and its relationship to therapy responseBMC Infectious Diseases, 2010
- Sequence variation in hepatitis C virus nonstructural protein 5A predicts clinical outcome of pegylated interferon/ribavirin combination therapy†Hepatology, 2008
- Sustained virological response based on rapid virological response in genotype-3 chronic hepatitis C treated with standard interferon in the Pakistani populationWorld Journal of Gastroenterology, 2008
- Antiviral therapy for chronic hepatitis C: past, present, and futureJournal of Gastroenterology, 2006
- Influence of the genetic heterogeneity of the ISDR and PePHD regions of hepatitis C virus on the response to interferon therapy in chronic hepatitis CJournal of Medical Virology, 2001